Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer

AJ Tije, Jaap Verweij, A Sparreboom, Ate van der Gaast, C Fowst, F Fiorentini, J Tursi, A Antonellini, M Mantel, C Hartman, Gerrit Stoter, AST Planting, Maja de Jonge

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2957-2964
Number of pages8
JournalClinical Cancer Research
Volume9
Publication statusPublished - 2003

Cite this